openPR Logo
Press release

Global Cemiplimab rwlc Market Top Leading Players with Strategies and Forecast 2028

03-24-2022 12:13 PM CET | Health & Medicine

Press release from: Orion Market Reseach

The global cemiplimab rwlc market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The cemiplimab injection is used to treat several types of CSCC that spread to nearby tissues and cannot be treated with surgery or radiation therapy. The rise in the incidence of basal cell carcinoma (BCC) is one of the major drivers for the growth of the global cemiplimab rwlc market. For instance, according to the data published by National Center for Biotechnology Information in 2021, BCC is the most common skin cancer in humans, with increasing incidence rates globally. Further, BCC is the most common in locations with greater UV exposure. Moreover, since the last 30 years, the estimated prevalence rates have risen from 20.0% to 80.0%. The incidence rate also increases with an increase in age, with the median age of diagnosis being 68 years. Also, the male gender is expected to have a high risk of mortality at twice the rate compared with women.
 
According to the data published by the Skin Cancer Foundation in 2019, is the most common form of skin cancer which is 5 times more prevalent than melanoma in the US. As per the same source, 1.8 million cases are diagnosed annually and 40000 cases are progressed to the advanced stage when cancer spreads and becomes difficult to treat. Moreover, the skin cancer foundation in coordination with Regeneron and Sanofi conducted a survey in 2019, which revealed 3 in 4 Americans (74.0%) are unaware of CSCC and 3.0% of Americans identified CSCC as a common type of cancer. Thus, the rise in the prevalence of CSCC across the globe is anticipated to drive the cemiplimab rwlc market global.
 
Looking towards the demand for cemiplimab rwlcs key market players are adopting various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in February 2021, Sanofi had received the USFDA approval for PD-1 inhibitor Libtayo (cemiplimab rwlc) as immunotherapy indicated for patients with advanced basal cell carcinoma(BCC) previously treated with hedgehog pathway inhibitor (HHI), and accelerated approval was granted for patients with metastatic BCC. Further, in November 2021, Verrica Pharmaceuticals Inc. has announced the USFDA acceptance for the company's Investigational New Drug Application (IND) for LTX-315, used for the treatment of basal cell carcinoma. Moreover, the company is anticipated to initiate its phase-2 trials in the first quarter of 2022.
 
In June 2020, Merck &Co. had received USFDA approval for Pembrolizumab for the treatment of patients with recurrent or metastatic CSCC that is not curable by surgery or radiation therapy. Thus, such product launches and approvals are anticipated to drive the growth of the global cemiplimab rwlc market.

(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Cemiplimab rwlc Market at https://orionmarketreports.com/request-sample/?id=92677&submit=Request+Sample%0D%0A

Market Coverage
 
The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- Merck & Co., Novartis International AG, and Sanofi SA among others.

A full report is available at: https://orionmarketreports.com/global-cemiplimab-rwlc-market/92677/
 
Global Cemiplimab rwlc Market Report by Segment
 
By Type
350mg Injection
Type2
By Application
Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)
Locally Advanced CSCC
 
 
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cemiplimab rwlc Market Top Leading Players with Strategies and Forecast 2028 here

News-ID: 2585971 • Views:

More Releases from Orion Market Reseach

Active Protection System Market Size Trends and Forecast by Application, Type, and Geography, Opportunity Analysis
Active Protection System Market Size Trends and Forecast by Application, Type, a …
The global active protection system market was valued at approximately USD 4.25 billion in 2023 and is projected to reach around USD 8.76 billion by 2034, indicating a compound annual growth rate (CAGR) of approximately 6.5% from 2024 to 2032. Active Protection System Market Overview The active protection system market is experiencing significant growth, driven by increasing global defense spending and the rising need for advanced military technologies to counter
Plant-based Snacks Market Future Prediction Report By 2032
Plant-based Snacks Market Future Prediction Report By 2032
The global plant-based snacks market was valued at approximately USD 45.9 billion in 2023 and is projected to reach USD 77.9 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.85% from 2024 to 2032. Plant-based Snacks Market Overview The plant-based snacks market has experienced significant growth in recent years, driven by increasing consumer awareness of health, sustainability, and ethical considerations. Consumers are increasingly seeking healthier snack alternatives
Expanded Polypropylene Packaging Market: Current Impact to Make Big Changes by 2032
Expanded Polypropylene Packaging Market: Current Impact to Make Big Changes by 2 …
Expanded Polypropylene Packaging Market size to grow from approximately USD 1.2 billion in 2023 to USD 2.4 billion by 2032, with a CAGR of 8.1% Expanded Polypropylene Packaging Market research report reveals important insights into market scenario to enable key players in taking calculated decision making. Basically, one of the major purposes of market research reports is to maximize the business growth opportunities. It also helps key players to turn business
Cyber Security Training Market Competitive Dynamics: SANS Institute, Coursera, IBM, Cybrary, Cisco, Check Point, CySA+
Cyber Security Training Market Competitive Dynamics: SANS Institute, Coursera, I …
Cyber Security Training Market: In 2023, the global cybersecurity awareness training market was valued at approximately USD 4.30 billion. It is projected to grow to around USD 21.12 billion by 2032, reflecting a compound annual growth rate (CAGR) of approximately 17.3% from 2024 to 2032. The global cybersecurity training market uses various applications and platforms to deliver training, assessment, and educational content. Common applications include learning management systems (LMS), virtual labs

All 5 Releases


More Releases for CSCC

Insights on the Ephrin Type B Receptor Market to 2027 | Industry Statistics, Eme …
The global ephrin type B receptor market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Eph receptors are a group of receptors that activates in response to binding with Eph receptor-interacting proteins (Ephrins). These receptors belong to the largest known subfamily of receptor tyrosine kinases (RTKs). The major factor contributing to the growth of the market is the increasing prevalence of cancer across the globe.
Cutaneous Squamous Cell Carcinoma Market to be at Forefront by 2027
Cutaneous Squamous Cell Carcinoma Market: Overview Cutaneous squamous cell carcinoma (cSCC) is a form of skin cancer which involves malignant proliferation of keratinizing cells of the epidermis and its appendages. It generally arises from precursor lesions such as actinic keratosis and Bowen’s disease. However, it can also grow de novo on irradiated skin with or without manifestations of chronic radio dermatitis, or on chronically inflamed skin such as in chronic inflammatory
A Spotlight on Mucopolysaccharidosis (MPS) Treatment Market from 2019 to 2023: A …
The exclusive research report on the Global Mucopolysaccharidosis (MPS) Treatment Market 2019 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global Mucopolysaccharidosis (MPS) Treatment Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe. Overview of Global Mucopolysaccharidosis (MPS) Treatment Market: This report studies the Global Mucopolysaccharidosis (MPS) Treatment
Global Cutaneous Squamous Cell Carcinoma (cSCC) Market 2018 Key Players: Vidac P …
Cutaneous Squamous Cell Carcinoma (cSCC) Market: WiseGuyReports.com adds “Cutaneous Squamous Cell Carcinoma (cSCC) Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting 2027” reports tits database. Executive Summary DelveInsight’s Cutaneous Squamous Cell Carcinoma (cSCC) - Market Insights, Epidemiology and Market Forecast-2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Cutaneous Squamous Cell Carcinoma (cSCC) in the United States, EU5 (Germany,
Cutaneous Squamous Cell Carcinoma – US market revenue will increase by double …
The estimated total number of incident cases of Cutaneous Squamous Cell Carcinoma (cSCC) in the US is expected to reach 713,294 by 2025 as per the latest report of DelveInsight. Non-melanoma skin cancer is the most common skin cancer in the United States. It is broadly classified into Basal cell carcinoma (BCC) and Squamous cell carcinoma (SCC). Basal cell carcinoma accounts for 75-80% of non-melanoma cancers and Squamous cell carcinoma
New Study Reveals Cutaneous Squamous cell Carcinoma-Market Insights, Epidemiolog …
Researchmoz added Most up-to-date research on "Cutaneous Squamous cell Carcinoma-Market Insights, Epidemiology and Market Forecast-2023" to its huge collection of research reports. DelveInsights Cutaneous Squamous Cell Carcinoma (cSCC)- Market Insights, Epidemiology and Market Forecast-2023-7MM report provides an overview of the disease and global market size of the Cutaneous Squamous Cell Carcinoma for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data